tiprankstipranks
Trending News
More News >
Scinai Immunotherapeutics (SCNI)
NASDAQ:SCNI
US Market

Scinai Immunotherapeutics (SCNI) Financial Statements

Compare
335 Followers

Scinai Immunotherapeutics Financial Overview

Scinai Immunotherapeutics's market cap is currently $737.84K. The company's EPS TTM is $-4.742; its P/E ratio is -0.07; Scinai Immunotherapeutics is scheduled to report earnings on December 2, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 658.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -580.00K$ -512.67K$ -559.80K$ -747.65K$ -708.92K
Operating Income$ -8.64M$ -9.71M$ -11.06M$ -10.87M$ 2.28M
EBITDA$ -6.99M$ -9.19M$ -10.50M$ -10.39M$ 2.75M
Net Income$ 4.80M$ -6.50M$ -5.80M$ -8.21M$ -1.39M
Balance Sheet
Cash & Short-Term Investments$ 1.96M$ 4.87M$ 14.07M$ 17.37M$ 2.93M
Total Assets$ 13.45M$ 17.47M$ 27.07M$ 32.04M$ 17.71M
Total Debt$ 2.09M$ 20.56M$ 21.54M$ 29.23M$ 20.90M
Net Debt$ 122.00K$ 15.69M$ 7.47M$ 11.86M$ 17.97M
Total Liabilities$ 3.47M$ 22.04M$ 28.83M$ 31.05M$ 22.25M
Stockholders' Equity$ 9.98M$ -4.57M$ -1.76M$ 982.00K$ -4.54M
Cash Flow
Free Cash Flow$ -6.35M$ -10.02M$ -8.10M$ -7.57M$ -24.48M
Operating Cash Flow$ -6.33M$ -9.38M$ -7.26M$ -7.43M$ -22.57M
Investing Cash Flow$ -12.00K$ -637.00K$ -836.00K$ -139.00K$ -1.85M
Financing Cash Flow$ 3.44M$ 1.09M$ 6.78M$ 21.43M$ 4.27M
Currency in USD

Scinai Immunotherapeutics Earnings and Revenue History

Scinai Immunotherapeutics Debt to Assets

Scinai Immunotherapeutics Cash Flow

Scinai Immunotherapeutics Forecast EPS vs Actual EPS